| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
247,384
|
218,983
|
177,751
|
231,857
| | Cost of Revenue | 141,557 | 118,649 | 89,353 | 125,302 | | |
Gross Profit
|
105,827
|
100,334
|
88,398
|
106,555
| |
|
Operating Expenses |
|
Research Development | 12,424 | 12,633 | 11,859 | 11,918 |
|
Selling General and Administrative | 67,374 | 67,238 | 61,675 | 70,049 |
|
Non Recurring | 2,289 | 27,538 | (1,387) | 85 |
|
Others | 7,747 | 7,834 | 7,813 | 7,537 |
|
|
|
Total Operating Expenses | 89,834 | 115,243 | 79,960 | 89,589 | | | |
Operating Income or Loss
|
15,993
|
(14,909)
|
8,438
|
16,966
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 520 | 466 | 508 | 780 |
|
Earnings Before Interest And Taxes | 16,513 | (14,443) | 8,946 | 17,746 |
|
Interest Expense | 3,192 | 3,261 | 3,260 | 3,583 |
|
Income Before Tax | 13,321 | (17,704) | 5,686 | 14,163 |
|
Income Tax Expense | 3,202 | (5,251) | 755 | 5,602 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 10,119 | (12,453) | 4,931 | 8,561 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
10,119
|
(12,453)
|
4,931
|
8,561
| | Preferred Stock And Other Adjustments | (262) | (330) | (290) | (270) | | |
Net Income Applicable To Common Shares
|
9,857
|
(12,783)
|
4,641
|
8,291
|
|